Institutional Ownership Monte Rosa Therapeutics, Inc. (GLUE)
This table provides information about the institutional ownership of Monte Rosa Therapeutics, Inc. (GLUE). We have compiled data on the 137 institutions that hold shares in the stock, with a total of 55.7 Million shares, which have been reported (via 13F filing form) to have a value of $800 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
383,268
shares
|
$5.5 Million
0.0% of portfolio
|
Q3 2025
Added 0.51%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Nov 14, 2025 Q3 2025 |
358,850
shares
|
$5.15 Million
0.06% of portfolio
|
Q3 2025
Added 32.22%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
307,049
shares
|
$4.41 Million
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2025 Q3 2025 |
269,643
shares
|
$3.87 Million
0.0% of portfolio
|
Q3 2025
Reduced 0.56%
|
|
|
Adar1 Capital Management, LLC
Austin, TX |
Nov 14, 2025 Q3 2025 |
215,752
shares
|
$3.1 Million
0.15% of portfolio
|
Q3 2025
New holding
|
|
|
Acadian Asset Management LLC
Boston, MA |
Nov 13, 2025 Q3 2025 |
203,550
shares
|
$2.92 Million
0.0% of portfolio
|
Q3 2025
Added 341.14%
|
|
|
Macquarie Group LTD
Australia, C3 |
Nov 13, 2025 Q3 2025 |
200,000
shares
|
$2.87 Million
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Td Asset Management Inc
|
Nov 10, 2025 Q3 2025 |
172,078
shares
|
$2.47 Million
0.0% of portfolio
|
Q1 2025
Reduced 21.82%
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
161,481
shares
|
$2.32 Million
0.0% of portfolio
|
Q3 2025
Reduced 32.7%
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2025 Q3 2025 |
158,524
shares
|
$2.28 Million
0.0% of portfolio
|
Q3 2025
Reduced 29.49%
|
|
|
Jbf Capital, Inc.
Aspen, CO |
Nov 14, 2025 Q3 2025 |
148,566
shares
|
$2.13 Million
0.16% of portfolio
|
Q3 2025
New holding
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
147,726
shares
|
$2.12 Million
0.0% of portfolio
|
Q3 2025
Reduced 27.38%
|
|
|
Gsa Capital Partners LLP
London, X0 |
Nov 07, 2025 Q3 2025 |
133,455
shares
|
$1.92 Million
0.08% of portfolio
|
Q3 2025
Reduced 52.98%
|
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
Nov 14, 2025 Q3 2025 |
118,383
shares
|
$1.7 Million
0.0% of portfolio
|
Q3 2025
Reduced 1.21%
|
|
|
Rangeley Capital, LLC
New Canaan, CT |
Nov 14, 2025 Q3 2025 |
113,000
shares
|
$1.62 Million
0.72% of portfolio
|
Q3 2025
New holding
|
|
|
Nuveen, LLC
Charlotte, NC |
Nov 12, 2025 Q3 2025 |
102,968
shares
|
$1.48 Million
0.0% of portfolio
|
Q2 2025
Reduced 12.5%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
102,835
shares
|
$1.48 Million
0.0% of portfolio
|
Q3 2024
Added 15.42%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
101,144
shares
|
$1.45 Million
0.0% of portfolio
|
Q3 2025
Reduced 70.95%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 13, 2025 Q3 2025 |
97,898
shares
|
$1.41 Million
0.0% of portfolio
|
Q3 2025
Added 49.72%
|
|
|
Squarepoint Ops LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
94,707
shares
|
$1.36 Million
0.0% of portfolio
|
Q3 2025
Reduced 46.83%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Nov 14, 2025 Q3 2025 |
90,419
shares
|
$1.3 Million
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Empowered Funds, LLC
|
Nov 13, 2025 Q3 2025 |
87,450
shares
|
$1.26 Million
0.01% of portfolio
|
Q3 2025
New holding
|
|
|
Casdin Capital, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
86,014
shares
|
$1.24 Million
0.09% of portfolio
|
Q3 2024
Reduced 67.05%
|
|
|
Mackenzie Financial Corp
Toronto Ontario, A6 |
Nov 13, 2025 Q3 2025 |
77,635
shares
|
$1.11 Million
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
72,955
shares
|
$1.05 Million
0.0% of portfolio
|
Q3 2025
Reduced 14.88%
|
|